Long-term impact of delay in assessment of patients with early arthritis

Arthritis and Rheumatism

Volumn 62, Issue 12, 2010, Pages 3537-3546

  Van Der Linden, Michael P M ^a   Le Cessie, Saskia ^a   Raza, Karim ^b   Van Der Woude, Diane ^a   Knevel, Rachel ^a   Huizinga, Tom W J ^a   Van Der Helm Van Mil, Annette H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DELAYED DIAGNOSIS; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HAZARD RATIO; HUMAN; JOINT DESTRUCTION; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SPONDYLARTHRITIS; THERAPY DELAY; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; COHORT STUDIES; DELAYED DIAGNOSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENERAL PRACTITIONERS; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650048259     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27692     Document Type: Article

References (29)

1. Wick MC, Lindblad S, Klareskog L, van Vollenhoven RF,. Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description. Ann Rheum Dis 2004; 63: 848-52.
2. Welsing PM, Landewe RB, van Riel PL, Boers M, van Gestel AM, van der Linden S, et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004; 50: 2082-93.
3. Quinn MA, Conaghan PG, Emery P,. The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatology (Oxford) 2001; 40: 1211-20.
4. Finckh A, Liang MH, van Herckenrode CM, de Pablo P,. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006; 55: 864-72.
5. Stenger AA, Van Leeuwen MA, Houtman PM, Bruyn GA, Speerstra F, Barendsen BC, et al. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. Br J Rheumatol 1998; 37: 1157-63.
6. Van Aken J, Lard LR, le Cessie S, Hazes JM, Breedveld FC, Huizinga TW,. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004; 63: 274-9.
7. Quinn MA, Emery P,. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003; 21: S154-7.
8. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS,. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004; 43: 906-14.
9. Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J, et al, for the FIN-RACo Trial Group. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002; 46: 894-8.
10. Van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC,. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003; 21: S100-5.
11. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37: 393-406.
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
13. Van der Heijde DM,. How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261-3]. J Rheumatol 1999; 26: 743-5.
14. Van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 2009; 60: 2262-71.
15. Van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, Raychaudhuri S, et al. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum 2009; 60: 2242-7.
16. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW,. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005; 7: R949-58.
17. Van der Helm-van Mil AH, Huizinga TW,. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008; 10: 205.
18. Van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW,. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007; 56: 433-40.
19. Van der Helm-van Mil AH, Detert J, le Cessie S, Filer A, Bastian H, Burmester GR, et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum 2008; 58: 2241-7.
20. Van Vollenhoven R, Ernestam S, Geborek P, Petersson I, Coster L, Waltbrand E, et al. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet 2009; 374: 459-66.
21. Lard LR, Huizinga TW, Hazes JM, Vliet Vlieland TP,. Delayed referral of female patients with rheumatoid arthritis. J Rheumatol 2001; 28: 2190-2.
22. Palm O, Purinszky E,. Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 2005; 64: 1227-8.
23. Suter LG, Fraenkel L, Holmboe ES,. What factors account for referral delays for patients with suspected rheumatoid arthritis? Arthritis Rheum 2006; 55: 300-5.
24. Sheppard J, Kumar K, Buckley CD, Shaw KL, Raza K,. 'I just thought it was normal aches and pains': a qualitative study of decision-making processes in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 1577-82.
25. Chan KW, Felson DT, Yood RA, Walker AM,. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 1994; 37: 814-20.
26. Kumar K, Daley E, Carruthers DM, Situnayake D, Gordon C, Grindulis K, et al. Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) 2007; 46: 1438-40.
27. Sandhu RS, Treharne GJ, Justice EA, Jordan AC, Saravana S, Obrenovic K, et al, on behalf of the West Midlands Rheumatology Services and Training Committee. Comment on: Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists [letter]. Rheumatology (Oxford) 2008; 47: 559-60.
28. Kumar K, Daley E, Khattak F, Buckley CD, Raza K,. The influence of ethnicity on the extent of, and reasons underlying, delay in general practitioner consultation in patients with RA. Rheumatology (Oxford) 2010; 49: 1005-12.
29. Feldman DE, Schieir O, Montcalm AJ, Bernatsky S, Baron M,. Rapidity of rheumatology consultation for people in an early inflammatory arthritis cohort. Ann Rheum Dis 2009; 68: 1790-1.